Filing metadata

Accession number
0001714899-22-000043
Form type
Form 5
Filer
Denali Therapeutics Inc.
CIK
CIK 1714899
Filed
Feb 17, 2022
Reporting period
Dec 31, 2021
Description
Annual insider statement

Explore SEC Filings Hub